1979
DOI: 10.1530/acta.0.0900451
|View full text |Cite
|
Sign up to set email alerts
|

Increased Insulin Sensitivity and Cellular Insulin Binding in Obese Diabetics Following Treatment With Glibenclamide

Abstract: The aim of the present study was to examine the effect of glibenclamide on the insulin receptors, the insulin sensitivity and the insulin secretion in obese non-ketotic diabetics.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
41
2

Year Published

1984
1984
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 137 publications
(46 citation statements)
references
References 7 publications
3
41
2
Order By: Relevance
“…It is well established that the insulin receptor capacity is inversely related to the insulin plasma levels in the state of insulin deficiency [22,23]. Decreasing insulin levels during sulphonylurea therapy were observed earlier by different investigators [19,20] and also recently by Lunetta et al [21] and by Beck-Nielsen et al [18] with adult-onset diabetic patients. (3) Another explanation for the discrepancy could be that factors as yet unknown might be involved, since in all experiments where an increase in insulin binding could be observed the drug was given orally.…”
Section: Discussionmentioning
confidence: 78%
See 1 more Smart Citation
“…It is well established that the insulin receptor capacity is inversely related to the insulin plasma levels in the state of insulin deficiency [22,23]. Decreasing insulin levels during sulphonylurea therapy were observed earlier by different investigators [19,20] and also recently by Lunetta et al [21] and by Beck-Nielsen et al [18] with adult-onset diabetic patients. (3) Another explanation for the discrepancy could be that factors as yet unknown might be involved, since in all experiments where an increase in insulin binding could be observed the drug was given orally.…”
Section: Discussionmentioning
confidence: 78%
“…Also an increased number of insulin receptors was observed in circulating monocytes of non-insulin-dependent diabetic patients treated with sulphonylureas [1,18]. It is at present not clear why these findings in vivo are not in agreement with the majority of studies in vitro.…”
Section: Discussionmentioning
confidence: 92%
“…Glibenclamide is a sulphonylurea which has been widely used in the management of non-insulin dependent diabetes mellitus [4][5][6] . Nevertheless, there are reports that glibenclamide can induce hypoglycemia, even at low doses, especially in the elderly 7,8 .…”
Section: Introductionmentioning
confidence: 99%
“…Although there are discordam results in the literature [15], the weight of experimental evidence indicates that sulfonylureas act in part by increasing sensitivity to insulin in peripheral tissues. Initial studies on the effects of sulfonylureas in peripheral tissues concentrated on possible changes in insulin receptor number [10,11,16,17] but recent attention has focused on post-receptor actions [5,8,12,13].…”
mentioning
confidence: 99%